MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

Source: 
BioPharma Dive
snippet: 

The joint venture with generative AI firm Hologen hands MeiraGTx $200 million up front as well as other financial perks — a “transformative” deal, according to the company’s CEO.